|
Asthma
|
COPD
|
Diabetes mellitus
|
Hypertension
|
Crohn’s disease
|
---|
Maximum GT observed value (March 2020)
|
Maximum GT predicted value (March 2020)
|
Maximum GT observed value (March 2020)
|
Maximum GT predicted value (March 2020)
|
Maximum GT observed value (March 2020)
|
Maximum GT predicted value (March 2020)
|
Maximum GT observed value (March 2020)
|
Maximum GT predicted value (March 2020)
|
Maximum GT observed value (March 2020)
|
Maximum GT predicted value (March 2020)
|
---|
Europe
|
Austria
|
67
|
29
|
42
|
37
|
71
|
94
|
45
|
45
|
21
|
26
|
Belgium
|
67
|
30
|
21
|
20
|
69
|
88
|
38
|
42
|
25
|
27
|
Bulgaria
|
27
|
26
|
17
|
14
|
86
|
97
|
78
|
75
|
6
|
17
|
Czech Republic
|
37
|
35
|
14
|
17
|
63
|
92
|
32
|
34
|
18
|
40
|
Denmark
|
87
|
27
|
26
|
31
|
82
|
92
|
13
|
14
|
14
|
14
|
Finland
|
76
|
34
|
10
|
15
|
67
|
77
|
31
|
27
|
13
|
17
|
France
|
100
|
25
|
24
|
12
|
68
|
60
|
51
|
44
|
22
|
31
|
Germany
|
87
|
30
|
53
|
34
|
68
|
88
|
41
|
44
|
18
|
20
|
Greece
|
52
|
20
|
27
|
15
|
73
|
93
|
31
|
33
|
13
|
32
|
Hungary
|
34
|
18
|
100
|
12
|
37
|
65
|
39
|
47
|
10
|
20
|
Ireland
|
100
|
29
|
45
|
28
|
84
|
78
|
49
|
40
|
29
|
28
|
Italy
|
41
|
29
|
11
|
12
|
78
|
32
|
74
|
67
|
13
|
32
|
Netherlands
|
64
|
21
|
27
|
21
|
60
|
74
|
29
|
37
|
14
|
15
|
Norway
|
100
|
28
|
11
|
23
|
55
|
70
|
49
|
32
|
14
|
23
|
Poland
|
28
|
18
|
11
|
8
|
44
|
78
|
24
|
33
|
10
|
12
|
Portugal
|
50
|
25
|
9
|
15
|
52
|
70
|
18
|
26
|
15
|
22
|
Romania
|
18
|
18
|
7
|
9
|
100
|
94
|
42
|
31
|
4
|
11
|
Russia
|
26
|
29
|
9
|
10
|
61
|
97
|
33
|
41
|
6
|
9
|
Spain
|
62
|
19
|
15
|
23
|
56
|
61
|
65
|
64
|
13
|
39
|
Sweden
|
41
|
14
|
12
|
15
|
41
|
44
|
32
|
20
|
7
|
8
|
Switzerland
|
100
|
26
|
28
|
22
|
56
|
59
|
62
|
34
|
14
|
21
|
Ukraine
|
24
|
25
|
10
|
8
|
75
|
100
|
37
|
47
|
7
|
10
|
United Kingdom
|
100
|
13
|
35
|
12
|
58
|
42
|
30
|
18
|
12
|
14
|
Africa
|
Egypt
|
8
|
8
|
3
|
4
|
55
|
86
|
10
|
14
|
69
|
4
|
South Africa
|
32
|
20
|
9
|
11
|
60
|
70
|
40
|
44
|
7
|
8
|
North America
|
Canada
|
69
|
23
|
31
|
24
|
95
|
100
|
46
|
55
|
18
|
22
|
USA
|
60
|
28
|
28
|
24
|
99
|
100
|
59
|
64
|
16
|
22
|
Latin America
|
Argentina
|
21
|
8
|
6
|
8
|
30
|
35
|
30
|
27
|
3
|
19
|
Brazil
|
52
|
25
|
11
|
8
|
87
|
96
|
72
|
59
|
8
|
25
|
Chile
|
49
|
26
|
11
|
17
|
64
|
87
|
64
|
69
|
8
|
10
|
Colombia
|
26
|
22
|
35
|
19
|
46
|
62
|
100
|
74
|
3
|
22
|
Ecuador
|
23
|
18
|
7
|
10
|
46
|
63
|
75
|
49
|
9
|
8
|
Mexico
|
19
|
19
|
12
|
12
|
76
|
87
|
69
|
67
|
3
|
5
|
Peru
|
39
|
26
|
5
|
9
|
64
|
87
|
57
|
51
|
4
|
6
|
Venezuela
|
31
|
28
|
5
|
12
|
48
|
63
|
71
|
71
|
3
|
10
|
Asia
|
Hong Kong
|
23
|
33
|
14
|
15
|
69
|
100
|
43
|
63
|
5
|
14
|
India
|
22
|
19
|
10
|
10
|
61
|
79
|
31
|
33
|
3
|
4
|
Indonesia
|
53
|
53
|
7
|
10
|
87
|
100
|
83
|
100
|
1
|
2
|
Iran
|
68
|
82
|
1
|
2
|
16
|
34
|
16
|
16
|
6
|
4
|
Israel
|
27
|
20
|
9
|
10
|
52
|
98
|
18
|
25
|
19
|
20
|
Japan
|
51
|
43
|
12
|
8
|
68
|
88
|
26
|
30
|
4
|
9
|
Malaysia
|
35
|
40
|
11
|
13
|
90
|
100
|
59
|
79
|
2
|
5
|
Pakistan
|
30
|
37
|
12
|
18
|
66
|
100
|
55
|
69
|
7
|
7
|
Philippines
|
87
|
59
|
20
|
20
|
78
|
100
|
81
|
91
|
5
|
7
|
Saudi Arabia
|
13
|
16
|
2
|
3
|
59
|
83
|
8
|
12
|
46
|
5
|
Singapore
|
19
|
20
|
7
|
9
|
47
|
78
|
37
|
81
|
3
|
7
|
South Korea
|
17
|
20
|
10
|
12
|
63
|
92
|
27
|
45
|
7
|
11
|
Taiwan
|
24
|
29
|
9
|
12
|
82
|
100
|
45
|
68
|
2
|
5
|
Thailand
|
16
|
20
|
10
|
12
|
81
|
100
|
40
|
56
|
3
|
3
|
Turkey
|
65
|
34
|
100
|
22
|
60
|
76
|
40
|
30
|
6
|
10
|
UAE
|
22
|
18
|
6
|
6
|
55
|
73
|
22
|
33
|
6
|
8
|
Vietnam
|
16
|
20
|
9
|
9
|
95
|
88
|
29
|
36
|
1
|
2
|
Pacific
|
Australia
|
77
|
48
|
28
|
24
|
85
|
94
|
45
|
42
|
17
|
23
|
New Zealand
|
91
|
36
|
39
|
25
|
76
|
100
|
33
|
42
|
19
|
28
|
- Maximum predicted values correspond to the maximum values of the upper bound of the 95% confidence intervals for predicted asthma GT. Numbers in italic indicate cases in which maximum GT observed values were higher than maximum predicted values
- COPD Chronic obstructive pulmonary disease, USA United States of America